首頁 > 市場調查報告書 > 醫療設備

整形外科美容整形

乳房重建市場規模、佔有率和成長分析（按產品、手術、類型、應用和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1899522

乳房重建市場規模、佔有率和成長分析（按產品、手術、類型、應用和地區分類）－2026-2033年產業預測

Breast Reconstruction Market Size, Share, and Growth Analysis, By Product (Breast Implant, Tissue Expander), By Procedure (Immediate Procedures, Delayed Procedures), By Type, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月16日 | 出版商:

SkyQuest | 英文 155 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，乳房重建市場規模將達到 6.2628 億美元，到 2025 年將達到 6.6886 億美元，到 2033 年將達到 11.3216 億美元，預測期（2026-2033 年）的複合年成長率為 6.8%。

全球乳房重建市場正經歷顯著成長，這主要得益於乳癌發生率的上升和有利的健保報銷政策。醫療技術的創新以及乳房重建手術數量的增加，共同推動了這一成長趨勢。醫療保險（Medicare）擴大了對癌症相關切除術乳房重建的覆蓋範圍，提高了患者的可及性，而乳房人工替代物的報銷政策也進一步支持了患者。主要行業參與者正透過推出新產品和進行宣傳活動來滿足不斷成長的需求。這些活動包括旨在教育女性了解乳房重建方案的項目，以及為服務不足人口提供免費重組手術的慈善活動。這些措施不僅促進了市場擴張，也提高了患者獲得必要服務的途徑。

乳房重建市場促進因素

乳房重建市場的主要驅動力是人們對美觀日益成長的興趣，尤其是在切除術。隨著患者對可供選擇的重組手術方案了解的不斷深入，對這些手術的需求也不斷增加。外科技術的進步不僅改善了手術效果，也使乳房重建更加普及和易於接受。媒體通報和宣傳活動進一步提升了人們的認知。此外，乳癌率的上升也凸顯了重組解決方案的必要性。社會對整形手術接受度的提高以及患者改善自身外觀的願望是推動該市場擴張的關鍵因素。

乳房重建市場的限制

由於涉及先進植入材料和技術的乳房重建市場面臨嚴峻的挑戰。患者常常面臨經濟壓力，尤其是在重組手術的保險覆蓋不足或缺失的情況下。包括術前諮詢、手術本身和術後護理在內的總費用，對許多人來說可能難以負擔。這種經濟負擔往往導致手術延期，對市場擴張產生負面影響。此外，區域經濟差距加劇了醫療服務可近性問題，使低收入者無法獲得必要的服務，進一步限制了市場的潛在覆蓋範圍和成長。

乳房重建市場趨勢

乳房重建市場正經歷著向微創技術的顯著轉變，這主要得益於外科技術的進步以及患者對微創手術方式日益成長的偏好。自體脂肪移植和內視鏡輔助乳房重建等手術因其能夠帶來卓越的美容效果，同時縮短恢復時間和減少疤痕，而越來越受歡迎。這些方法能夠幫助患者快速恢復日常活動，並將術後不適感降至最低，進而提高患者滿意度。技術創新有望顯著改變乳房重建領域，而微創手術方式預計將成為推動這一市場趨勢的關鍵因素。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲（MEA）
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭格局

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市集活動
主要企業市佔率（2025 年）

主要企業簡介

Johnson & Johnson（US）
Allergan Aesthetics（AbbVie）（US）
Ideal Implant Incorporated（US）
Sebbin（France）
GC Aesthetics（Ireland）
POLYTECH Health & Aesthetics（Germany）
Sientra（US）
Integra Lifesciences（US）
RTI Surgical Holdings（US）
Establishment Labs SA（US）
Silimed（Brazil）
Laboratories Arion（France）
Guangzhou Wanhe Plastic Materials Co. Ltd.（China）
CEREPLAS（France）
HansBiomed（South Korea）
PMT Corporation（US）
Shanghai Kangning Medical Device（China）
Biodermis（USA）
Surgiform Technology, Ltd.（USA）
Motiva Implants（Costa Rica）

簡介目錄

Product Code: SQMIG35A2947

Breast Reconstruction Market size was valued at USD 626.28 Million in 2024 and is poised to grow from USD 668.86 Million in 2025 to USD 1132.16 Million by 2033, growing at a CAGR of 6.8% during the forecast period (2026-2033).

The Global Breast Reconstruction market is experiencing significant growth driven by the increasing prevalence of breast cancer and supportive reimbursement policies. Innovations in medical technology, combined with a rise in the number of breast reconstruction procedures, are contributing to this upward trend. Coverage from Medicare for breast reconstruction following mastectomy due to cancer enhances accessibility, while reimbursement schemes for breast prostheses further support patients. Major industry players are responding to the growing demand by launching new products and promoting awareness initiatives. Efforts include programs aimed at educating women about breast reconstruction options, as well as philanthropic initiatives that provide free reconstruction surgeries for underserved populations. These developments not only foster market expansion but also enhance patient access to essential services.

Top-down and bottom-up approaches were used to estimate and validate the size of the Breast Reconstruction market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Breast Reconstruction Market Segments Analysis

Global Breast Reconstruction Market is segmented by Product, Procedure, Type, End User, and region. Based on Product, the market is segmented into Breast Implant (Silicone Implants, Saline Implants), Tissue Expander (Saline Tissue Expander, Air Tissue Expander), Acellular Dermal Matrix. Based on Procedure, the market is segmented into Immediate Procedures, Delayed Procedures, Revision Procedures. Based on Type, the market is segmented into Unilateral Breast Reconstruction, and Bilateral. Based on End User, the market is segmented into Hospitals & Clinics, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Breast Reconstruction Market

The breast reconstruction market is significantly driven by the heightened focus on aesthetics, especially in the aftermath of mastectomy. Patients are increasingly aware of the reconstructive surgery options available to them, which has led to a rise in demand for these procedures. Advancements in surgical techniques have not only improved the outcomes but also made breast reconstruction more accessible and acceptable. Media coverage and educational initiatives further promote this awareness. Additionally, the rising incidence of breast cancer underscores the necessity for reconstructive solutions. The growing societal acceptance of cosmetic enhancements and the quest for improved appearances among patients are essential factors fueling the expansion of this market.

Restraints in the Breast Reconstruction Market

The breast reconstruction market faces significant challenges due to high expenses associated with surgeries, including advanced implant materials and techniques. Patients frequently struggle with financial concerns, particularly when insurance coverage for reconstructive procedures is inadequate or non-existent. The overall costs-including pre-operative consultations, the surgical procedure, and post-operative care-can be prohibitively expensive for many individuals. This financial burden often results in postponed procedures, which negatively impacts market expansion. Additionally, economic disparities across different regions can exacerbate access issues, preventing lower-income populations from obtaining necessary services and further restricting the market's potential reach and growth.

Market Trends of the Breast Reconstruction Market

The breast reconstruction market is witnessing a pronounced shift towards less invasive techniques, driven by advancements in surgical technologies and an increasing patient preference for minimal intervention. Techniques such as autologous fat grafting and endoscopic-assisted breast reconstruction are gaining popularity due to their ability to deliver superior aesthetic outcomes while reducing recovery time and scarring. These methods enhance patient satisfaction by enabling quicker returns to daily activities and minimizing postoperative discomfort. As technological innovations continue to evolve, it is anticipated that the landscape of breast reconstruction will be significantly transformed, with less invasive options leading the charge in this market trend.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Innovation Matrix
Ecosystem of the Market
Regulatory Landscape
Technology Analysis
Patent Analysis
PESTEL Analysis
Market Attractiveness Index, 2025

Breast Reconstruction Market, By Product

Market Overview
Breast Implant
- Silicone Implants
- Round
- Anatomical
- Saline Implants
- Round
- Anatomical
Tissue Expander
- Saline Tissue Expander
- Air Tissue Expander
Acellular Dermal Matrix

Breast Reconstruction Market, By Procedure

Market Overview
Immediate Procedures
Delayed Procedures
Revision Procedures

Breast Reconstruction Market, By Type

Market Overview
Unilateral Breast Reconstruction
Bilateral

Breast Reconstruction Market, By End User

Market Overview
Hospitals & Clinics
Ambulatory Surgical Centers
Others

Breast Reconstruction Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Johnson & Johnson (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allergan Aesthetics (AbbVie) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ideal Implant Incorporated (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sebbin (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GC Aesthetics (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
POLYTECH Health & Aesthetics (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sientra (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra Lifesciences (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RTI Surgical Holdings (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Establishment Labs S.A. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Silimed (Brazil)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Laboratories Arion (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Guangzhou Wanhe Plastic Materials Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CEREPLAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
HansBiomed (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PMT Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shanghai Kangning Medical Device (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biodermis (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Surgiform Technology, Ltd. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Motiva Implants (Costa Rica)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments